Thursday, February 10, 2022 9:38:29 PM
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165885459
HGEN stock is now completely 100% de-risked. The continued government funding for the ACTIV-5 trial strongly indicates that they still support giving lenzilumab an EUA for Covid. And now the stock is the bargain basement price of $6.11 making HGEN's market cap a measly $384 million. The CAR-T indication alone is worth far more than that. Zero risk investing in HGEN at this price point but it has the potential to be a 10-bagger if/when the EUA comes.
100% of my portfolio is now invested in HGEN. Rise like a phoenix from the ashes.
Maybe you should have listened to me... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165897997
I do have to say, it's very impressive how happy HGEN shareholders are given they are down 50-90% on their holdings and they also still think Management is doing a great job.
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM
Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM